Bayer M F, Macoviak J A, McDougall I R
Department of Diagnostic Radiology, Stanford University School of Medicine, CA 94305.
Clin Chem. 1987 Dec;33(12):2178-84.
Serum thyrotropin (TSH) concentrations were measured serially in 14 heart-transplant recipients (group 1) and 21 patients undergoing coronary artery bypass surgery (group 2), all without thyroid disease, and randomly in 158 patients hospitalized for various other nonthyroidal illnesses, including 144 judged euthyroid (group 3), six with increased FT4 and (or) T3 (group 4), and eight classified hypothyroid by conventional tests. The serial measurements indicated profound fluctuations. In group 1, TSH was subnormal in 21% of studies and increased in 10%. In group 2, corresponding abnormalities were found in 7% and 13%, respectively. Transiently low or high TSH tended to be associated with normal free thyroxin (FT4), prolonged subnormal TSH (greater than 1 week) with subnormal FT4. By contrast, subnormal TSH plus elevated FT4, or high TSH plus low FT4, were not encountered, making it unlikely that they occur by chance in severely ill patients who are not also hyper- or hypothyroid. In group 3, a suppressed TSH (plus borderline high FT4, T3/FT3) identified four cases of subclinical hyperthyroidism; however, another 11% of patients had subnormal and 10% had above-normal TSH, paired with normal FT4 and no evidence of thyroid disease. In group 4, suppressed TSH confirmed hyperthyroidism in five of six patients, and all in group 5 had increased TSH. We conclude that, in the hospital setting, sensitive TSH measurement can help to detect or confirm mild hyperthyroidism, but the positive predictive value of TSH alone may be as low as 35%.
对14名心脏移植受者(第1组)和21名接受冠状动脉搭桥手术的患者(第2组)进行了促甲状腺激素(TSH)血清浓度的连续测量,所有患者均无甲状腺疾病,并对158名因各种其他非甲状腺疾病住院的患者进行了随机测量,其中包括144名甲状腺功能正常者(第3组)、6名游离甲状腺素(FT4)和(或)T3升高者(第4组),以及8名经传统检测分类为甲状腺功能减退者。连续测量显示有显著波动。在第1组中,21%的检测中TSH低于正常水平,10%的检测中TSH升高。在第2组中,相应的异常分别为7%和13%。TSH短暂降低或升高往往与游离甲状腺素(FT4)正常有关,TSH持续低于正常水平(超过1周)与FT4低于正常水平有关。相比之下,未发现TSH低于正常水平且FT4升高,或TSH升高且FT4降低的情况,这使得它们不太可能在非甲状腺功能亢进或减退的重症患者中偶然出现。在第3组中,TSH受抑制(加上FT4、T3/FT3临界升高)确定了4例亚临床甲状腺功能亢进病例;然而,另有11%的患者TSH低于正常水平,10%的患者TSH高于正常水平,同时FT4正常且无甲状腺疾病证据。在第4组中,TSH受抑制证实6名患者中有5名甲状腺功能亢进,第5组所有患者的TSH均升高。我们得出结论,在医院环境中,敏感的TSH测量有助于检测或确诊轻度甲状腺功能亢进,但仅TSH的阳性预测价值可能低至35%。